Allscripts' UK Growth Recognised in KLAS EMR Report

AllscriptsAllscripts’ rapid growth in the UK and high levels of customer satisfaction have been recognised in a KLAS performance report into the European electronic medical record market. The independent research, which tracks contract wins and the views of healthcare professionals about vendors and products, says Europe is 'one of the most dynamic and competitive EMR markets in the world.'

In this environment, Allscripts has gone from having one English customer for its Sunrise electronic patient record in 2011, to eight today.

KLAS reports that the five go-lives covered by its research "have progressed successfully". It also summarises structured interviews with customers by saying: "Customers like the product and feel it is powerful and can do a lot. Customers are generally pleased with what they have achieved."

Steven Brain, vice president and managing director, UK, Allscripts, said: "This is an exciting time for healthcare IT in England. We have a new health and social care secretary who has made technology one of his three priorities, and a new ten year-plan for the NHS in development that will be 'digitally enabled at its heart'.

"Trusts are looking for digitisation partners to support their electronic patient record ambitions and help them share information and insights across increasingly integrated healthcare economies. So, it is good to see that KLAS has recognised the progress made by Allscripts, and the confidence of our customers in our product and team.

"We are the only company that can provide a clinical wrap for trusts that enables them to retain their patient administration system and core IT investments, while adding key clinical functionality. The KLAS research shows trusts can be confident in this approach."

The KLAS report is based on market intelligence and interviews with healthcare professionals about the products and services they use. The interviews are conducted using a standard quantitative evaluation methodology, from which performance scores can be calculated.

Allscripts was given an overall performance score of 80.1 out of 100 for the UK and Ireland; significantly above the market average. It scored particularly well on 'quality of implementation' (7.4 on a nine-point scale), overall quality of product (7.4), and forecasted overall satisfaction (7.6).

Nine out of ten customers interviewed said they would buy Sunrise again (89%) and that it was part of their long-term plan (90%). All the customers interviewed expressed confidence in cost (100% said Allscripts avoided unexpected costs).

In interviews, customers also praised the support they received from the Allscripts team in the UK, with comments including: "Allscripts was good during our entire implementation", "we have been working really well with them and are very happy with them", "other vendors sign on the dotted line and kind-of disappear, but that is not the case with Allscripts" and "Allscripts keep their promises whenever they can."

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations.

Most Popular Now

AI-Pathway Companion Prostate Cancer fro…

AI-Pathway Companion Prostate Cancer(2), a digital companion from Siemens Healthineers to support clinical decision-making, has recently received the CE mark for use in the clinical pathway of prostate cancer, the...

Philips Launches HealthSuite System of E…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the HealthSuite System of Engagement, an integrated, modular set of standards-based capabilities that support the development...

AI may Help Spot Newborns at Risk for Mo…

An artificial intelligence (AI) device that has been fast-tracked for approval by the Food and Drug Administration may help identify newborns at risk for aggressive posterior retinopathy of prematurity (AP-ROP)...

International Scientific Symposium DigiH…

13 November 2020, Pfarrkirchen, Germany DigiHealthDay @DIT-ECRI is going to be a daylong action-packed event targeting primarily academia - from established researchers, to young scientists and students. Following the theme "How...

Siemens Healthineers Introduces Teamplay…

Siemens Healthineers announces market introduction of the teamplay digital health platform. With the teamplay digital health platform Siemens Healthineers paves the way for healthcare providers' digital transformation - facilitating easy...

Digital Heart Model will Help Predict Fu…

In recent times, researchers have increasing found that the power of computers and artificial intelligence is enabling more accurate diagnosis of a patient's current heart health and can provide an...

Fighting Hand Tremors: First comes AI, t…

Robots hold promise for a large number of people with neurological movement disorders severely affecting the quality of their lives. Now researchers have tapped artificial intelligence techniques to build an...

Portable AI Device Turns Coughing Sounds…

University of Massachusetts Amherst researchers have invented a portable surveillance device powered by machine learning - called FluSense - which can detect coughing and crowd size in real time, then...

Oxford University Provide Evidence for C…

A team of medical research and bioethics experts at Oxford University are supporting several European governments to explore the feasibility of a coronavirus mobile app for instant contact tracing. If...

Buddy Healthcare Launches COVID-19 Remot…

Buddy Healthcare wants to help hospitals and healthcare professionals in the battle against the COVID-19. BuddyCare virtual care platform can be used for not only symptom tracking, remote monitoring and...

Preventicus Appoints Ljubisav Matejevic …

Preventicus is proud to announce that the company continues to grow by bringing its unique, comprehensive care management programs for prevention of strokes and cardiovascular events to new international markets...